Article Text

Download PDFPDF

Namaste Care in nursing care homes for people with advanced dementia: protocol for a feasibility randomised controlled trial
  1. Katherine Froggatt1,
  2. Shakil Patel1,
  3. Guillermo Perez Algorta1,
  4. Frances Bunn2,
  5. Girvan Burnside3,
  6. Joanna Coast4,
  7. Lesley Dunleavy1,
  8. Claire Goodman2,
  9. Ben Hardwick3,
  10. Julie Kinley5,
  11. Nancy J Preston1,
  12. Catherine Walshe1
  1. 1 International Observatory on End of Life Care, Lancaster University, Lancaster, UK
  2. 2 Department of Health and Human Sciences, University of Herfordshire, Hatfield, UK
  3. 3 Clinical Trials Research Centre, The University of Liverpool, Liverpool, UK
  4. 4 University of Bristol, Bristol, UK
  5. 5 St Chrisptophers Hospice, London, UK
  1. Correspondence to Dr Katherine Froggatt; k.froggatt{at}lancaster.ac.uk

Abstract

Introduction Many people living with advanced dementia live and die in nursing care homes. The quality of life, care and dying experienced by these people is variable. Namaste Care is a multisensory programme of care developed for people with advanced dementia. While there is emerging evidence that Namaste Care may be beneficial for people with dementia, there is a need to conduct a feasibility study to establish the optimum way of delivering this complex intervention and whether benefits can be demonstrated in end-of-life care, for individuals and service delivery. The aim of the study is to ascertain the feasibility of conducting a full trial of the Namaste Care intervention.

Methods and analysis A feasibility study, comprising a parallel, two-arm, multicentre cluster controlled randomised trial with embedded process and economic evaluation. Nursing care homes (total of eight) who deliver care to those with advanced dementia will be randomly allocated to intervention (delivered at nursing care home level) or control. Three participant groups will be recruited: residents with advanced dementia, informal carers of a participating resident and nursing care home staff. Data will be collected for 6 months. Feasibility objectives concern the recruitment and sampling of nursing homes, residents, informal carers and staff; the selection and timing of primary (quality of dying and quality of life) and secondary clinical outcome measures (person centredness, symptom presence, agitation, quality of life, resource use and costs and residents’ activity monitored using actigraphy). Acceptability, fidelity and sustainability of the intervention will be assessed using semistructured interviews with staff and informal carers.

Ethics and dissemination This protocol has been approved by NHS Wales Research Ethics Committee 5 (ref: 17/WA0378). Dissemination plans include working with a public involvement panel, through a website (http://www.namastetrial.org.uk), social media, academic and practice conferences and via peer reviewed publications.

Trial registration number ISRCTN14948133; Pre-results.

  • dementia
  • namaste care
  • feasibility study
  • randomised controlled trial
  • palliative care
  • nursing care homes

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Twitter @NamasteResearch

  • Contributors KF, GPA, FB, GB, JC, CG, JK, NJP and CW were involved in the conception and design of the trial. SP and KF were involved in the drafting of the article GPA, FB, GB, JC, LD, CG, BH, JK, NJP and CW were involved in critical revision of the article for important intellectual content. All authors were involved in the final approval of the manuscript.

  • Funding This work was supported by the National Institute of Health Research, HTA programme grant number 15/10/11.

  • Disclaimer The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NHS, NIHR or the Department of Health and Social Care.

  • Competing interests None declared.

  • Patient consent Not required.

  • Ethics approval Wales Research Ethics Committee 5, UK.

  • Provenance and peer review Not commissioned; peer reviewed for ethical and funding approval prior to submission.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.